Stephen Taub Hedge Funds Surface in Wave of Biopharma SPAC Deals RTW and Perceptive Advisors are among investors seen in recent SPAC deals in biopharma. Stephen Taub October 19, 2020 Joseph Edelman, CEO of Perceptive Advisors. (Chris Goodney/Bloomberg)